Current and historical daily PE Ratio for Rohto Pharmaceutical Co Ltd (
TSE:4527
) from 1990 to Jun 01 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Rohto Pharmaceutical stock (TSE:4527) PE ratio as of Jun 01 2024 is 20.42.
More Details
Rohto Pharmaceutical Co Ltd (TSE:4527) PE Ratio (TTM) Chart
Rohto Pharmaceutical Co Ltd (TSE:4527) PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1263
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Rohto Pharmaceutical PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-01 | 20.4 | 2024-03-27 | 22.9 |
| 2024-05-31 | 20.4 | 2024-03-26 | 23.1 |
| 2024-05-30 | 20.1 | 2024-03-25 | 23.4 |
| 2024-05-29 | 19.8 | 2024-03-22 | 23.3 |
| 2024-05-28 | 20.1 | 2024-03-21 | 23.5 |
| 2024-05-27 | 20.1 | 2024-03-19 | 23.3 |
| 2024-05-24 | 20.4 | 2024-03-18 | 23.1 |
| 2024-05-23 | 20.8 | 2024-03-15 | 22.6 |
| 2024-05-22 | 20.2 | 2024-03-14 | 22.6 |
| 2024-05-21 | 20.8 | 2024-03-13 | 21.2 |
| 2024-05-20 | 21.3 | 2024-03-12 | 21.7 |
| 2024-05-17 | 21.3 | 2024-03-11 | 21.5 |
| 2024-05-16 | 21.4 | 2024-03-08 | 21.8 |
| 2024-05-15 | 21.4 | 2024-03-07 | 22.1 |
| 2024-05-14 | 22.1 | 2024-03-06 | 22.1 |
| 2024-05-13 | 23.5 | 2024-03-05 | 22.2 |
| 2024-05-10 | 23.7 | 2024-03-04 | 22.2 |
| 2024-05-09 | 23.3 | 2024-03-01 | 22.3 |
| 2024-05-08 | 22.8 | 2024-02-29 | 22.5 |
| 2024-05-07 | 22.5 | 2024-02-28 | 22.6 |
| 2024-05-02 | 22.7 | 2024-02-27 | 22.3 |
| 2024-05-01 | 22.8 | 2024-02-26 | 22.5 |
| 2024-04-30 | 22.8 | 2024-02-22 | 22.2 |
| 2024-04-26 | 22.4 | 2024-02-21 | 22.1 |
| 2024-04-25 | 21.9 | 2024-02-20 | 21.8 |
| 2024-04-24 | 21.6 | 2024-02-19 | 21.8 |
| 2024-04-23 | 22.1 | 2024-02-16 | 22.0 |
| 2024-04-22 | 22.0 | 2024-02-15 | 21.3 |
| 2024-04-19 | 21.6 | 2024-02-14 | 22.5 |
| 2024-04-18 | 21.3 | 2024-02-13 | 23.1 |
| 2024-04-17 | 21.1 | 2024-02-09 | 21.9 |
| 2024-04-16 | 21.2 | 2024-02-08 | 22.1 |
| 2024-04-15 | 22.0 | 2024-02-07 | 22.4 |
| 2024-04-12 | 21.9 | 2024-02-06 | 22.7 |
| 2024-04-11 | 21.7 | 2024-02-05 | 22.7 |
| 2024-04-10 | 21.6 | 2024-02-02 | 22.4 |
| 2024-04-09 | 21.5 | 2024-02-01 | 22.5 |
| 2024-04-08 | 21.7 | 2024-01-31 | 22.5 |
| 2024-04-05 | 21.3 | 2024-01-30 | 22.4 |
| 2024-04-04 | 22.3 | 2024-01-29 | 22.6 |
| 2024-04-03 | 22.4 | 2024-01-26 | 22.6 |
| 2024-04-02 | 22.0 | 2024-01-25 | 22.1 |
| 2024-04-01 | 22.2 | 2024-01-24 | 22.2 |
| 2024-03-29 | 21.9 | 2024-01-23 | 22.2 |
| 2024-03-28 | 21.7 | 2024-01-22 | 22.3 |
Rohto Pharmaceutical Co Ltd (TSE:4527) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Rohto Pharmaceutical Co Ltd
ISIN : JP3982400008
Share Class Description:
TSE:4527: Ordinary SharesDescription
Rohto Pharmaceutical Co Ltd is a Japan-based manufacturer and marketer of pharmaceutical products, cosmetics, and functional foods. It undertakes manufacture and sales activities mainly in the health and beauty care categories. The company comprises the four geographical reportable segments of Japan, America, Europe, and Asia. In each segment, it manufactures and sales eye care products including eye drops and eyewash preparations, skincare products including dermal medicines, lip balm, sunscreens, and functional cosmetics, among others, internal medicines and food products including gastrointestinal medicines, traditional Chinese herbal medicines and supplements, and other products and services, such as in-vitro test kits.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers